Authors:
VOORN DA
KUIPER CM
NOORDHUIS P
SMID K
SANDVOLD ML
MYHREN F
HENDRIKS HR
PETERS GJ
Citation: Da. Voorn et al., BIOLOGIC ACTIVITY OF LIPOPHILIC 1-B-D-ARABINOFURANOSYLCYTOSINE (ARA-C) DERIVATIVES - CELL-SPECIFIC CYTOTOXICITY AND STRUCTURE-ACTIVITY RELATIONSHIP (SAR), Annals of oncology, 9, 1998, pp. 119-119
Authors:
MCSHEEHY P
KRALOVANSKY J
JENEY A
PANDI E
KATONA C
NOORDHUIS P
PETERS G
RODRIGUES L
GRIFFITHS J
Citation: P. Mcsheehy et al., INVESTIGATIONS OF MODULATION OF 5-FLUOROURACIL (FU) PHARMACOKINETICS BY 5-ETHYL-2'-DEOXYURIDINE (EUDR) IN TUMOR-BEARING MICE AND RATS, Annals of oncology, 9, 1998, pp. 581-581
Authors:
ROTS MG
NOORDHUIS P
WILLEY JC
VANZANTWIJK CH
DEMUTH JP
VEERMAN AJP
PIETERS R
PETERS GJ
JANSEN G
Citation: Mg. Rots et al., EXPRESSION OF MESSENGER-RNA ENCODING FOR THE REDUCED FOLATE CARRIER AND FOLATE METABOLIZING ENZYMES IN CHILDHOOD LEUKEMIA-CELLS AS MEASUREDWITH A COMPETITIVE TEMPLATE RT-PCR METHOD, Annals of oncology, 9, 1998, pp. 620-620
Authors:
ELGIE AW
SARGENT JM
ALTON P
PETERS GJ
NOORDHUIS P
WILLIAMSON CJ
TAYLOR CG
Citation: Aw. Elgie et al., MODULATION OF RESISTANCE TO ARA-C BY BRYOSTATIN IN FRESH BLAST CELLS FROM PATIENTS WITH AML, Leukemia research, 22(4), 1998, pp. 373-378
Authors:
JANSEN G
MAURITZ R
DRORI S
SPRECHER H
KATHMANN I
BUNNI M
PRIEST DG
NOORDHUIS P
SCHORNAGEL JH
PINEDO HM
PETERS GJ
ASSARAF YG
Citation: G. Jansen et al., A STRUCTURALLY ALTERED HUMAN REDUCED FOLATE CARRIER WITH INCREASED FOLIC-ACID TRANSPORT MEDIATES A NOVEL MECHANISM OF ANTIFOLATE RESISTANCE, The Journal of biological chemistry, 273(46), 1998, pp. 30189-30198
Authors:
CODACCIPISANELLI G
KRALOVANSZKY J
VANDERWILT CL
NOORDHUIS P
COLOFIORE JR
MARTIN DS
FRANCHI F
PETERS GJ
Citation: G. Codaccipisanelli et al., MODULATION OF 5-FLUOROURACIL IN MICE USING URIDINE DIPHOSPHOGLUCOSE, Clinical cancer research, 3(2), 1997, pp. 309-315
Authors:
VANGROENINGEN CJ
SCHORNAGEL JH
PETERS GJ
NOORDHUIS P
VANKUILENBURG ABP
SHIRASAKA T
SHIMAMURA Y
DEVRIES MJ
HANAUSKE AR
Citation: Cj. Vangroeningen et al., A PHASE-I STUDY WITH S-1, AN ORAL 5-FU FORMULATION, IN PATIENTS WITH SOLID TUMORS, European journal of cancer, 33, 1997, pp. 1104-1104
Authors:
VANDERWILT CL
SMID K
AHERNE GW
NOORDHUIS P
PETERS GJ
Citation: Cl. Vanderwilt et al., BIOCHEMICAL-MECHANISMS OF INTERFERON MODULATION OF 5-FLUOROURACIL ACTIVITY IN COLON-CANCER CELLS, European journal of cancer, 33(3), 1997, pp. 471-478
Authors:
VANLAAR JAM
VANDERWILT CL
RUSTUM YM
NOORDHUIS P
SMID K
PINEDO HM
PETERS GJ
Citation: Jam. Vanlaar et al., THERAPEUTIC EFFICACY OF FLUOROPYRIMIDINES DEPENDS ON THE DURATION OF THYMIDYLATE SYNTHASE INHIBITION IN THE MURINE COLON 26-B CARCINOMA TUMOR-MODEL, Clinical cancer research, 2(8), 1996, pp. 1327-1333
Authors:
VEERMAN G
VANHAPEREN VWTR
VERMORKEN JB
NOORDHUIS P
BRAAKHUIS BJM
PINEDO HM
PETERS GJ
Citation: G. Veerman et al., ANTITUMOR-ACTIVITY OF PROLONGED AS COMPARED WITH BOLUS ADMINISTRATIONOF 2',2'-DIFLUORODEOXYCYTIDINE IN-VIVO AGAINST MURINE COLON TUMORS, Cancer chemotherapy and pharmacology, 38(4), 1996, pp. 335-342
Authors:
NOORDHUIS P
KAZEMIER KM
KASPERS GJL
PETERS GJ
Citation: P. Noordhuis et al., MODULATION OF METABOLISM AND CYTOTOXICITY OF CYTOSINE-ARABINOSIDE WITH N-(PHOSPHON)-ACETYL-L-ASPARTATE IN HUMAN LEUKEMIC BLAST CELLS AND CELL-LINES, Leukemia research, 20(2), 1996, pp. 127-134
Authors:
POORTER RL
PETERS GJ
BAKKER PJM
TAAT CW
BIERMANSVANLEEUWE DMJ
CODACCIPISANELLI G
NOORDHUIS P
OOSTING J
VEENHOF CHN
Citation: Rl. Poorter et al., INTERMITTENT CONTINUOUS-INFUSION OF 5-FLUOROURACIL AND LOW-DOSE ORAL LEUCOVORIN IN PATIENTS WITH GASTROINTESTINAL CANCER - RELATIONSHIP BETWEEN PLASMA-CONCENTRATIONS AND CLINICAL-PARAMETERS, European journal of cancer, 31A(9), 1995, pp. 1465-1470
Authors:
CODACCIPISANELLI G
VANDERWILT CL
PINEDO HM
FRANCHI F
NOORDHUIS P
BRAAKHUIS BJM
VANLAAR JAM
PETERS GJ
Citation: G. Codaccipisanelli et al., ANTITUMOR-ACTIVITY, TOXICITY AND INHIBITION OF THYMIDYLATE SYNTHASE OF PROLONGED ADMINISTRATION OF 5-FLUOROURACIL IN MICE, European journal of cancer, 31A(9), 1995, pp. 1517-1525
Authors:
VANKUILENBURG ABP
POORTER RL
PETERS GJ
VANLENTHE H
STROOMER AEM
VANGENNIP AH
SMID K
NOORDHUIS P
BAKKER PJM
VEENHOF CHN
Citation: Abp. Vankuilenburg et al., CIRCADIAN VARIATION OF DIHYDROPYRIMIDINE DEHYDROGENASE (DPD), URIDINEPHOSPHORYLASE (UP), BETA-ALANINE (BETA-ALA) AND 5-FLUOROURACIL, (5-FU) DURING CONTINOUS INFUSION (CI) FLUOROPYRIMIDINES (FP), European journal of cancer, 31A, 1995, pp. 954-954
Authors:
PETERS GJ
NOORDHUIS P
KOMISSAROV A
HOLWERDA U
KOK RM
VANLAAR JAM
VANDERWILT CL
VANGROENINGEA CJ
PINEDO HM
Citation: Gj. Peters et al., QUANTIFICATION OF 5-FLUOROURACIL INCORPORATION INTO RNA OF HUMAN AND MURINE TUMORS AS MEASURED WITH A SENSITIVE GAS-CHROMATOGRAPHY MASS-SPECTROMETRY ASSAY, Analytical biochemistry, 231(1), 1995, pp. 157-163
Authors:
VANHAPEREN VWTR
VEERMAN G
BOVEN E
NOORDHUIS P
VERMORKEN JB
PETERS GJ
Citation: Vwtr. Vanhaperen et al., SCHEDULE DEPENDENCE OF SENSITIVITY TO 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) IN RELATION TO ACCUMULATION AND RETENTION OF ITS TRIPHOSPHATE IN SOLID TUMOR-CELL LINES AND SOLID TUMORS, Biochemical pharmacology, 48(7), 1994, pp. 1327-1339
Authors:
PETERS GJ
WETS M
KEEPERS YPAM
OSKAM R
VANARKOTTE J
NOORDHUIS P
SMID K
PINEDO HM
Citation: Gj. Peters et al., TRANSFORMATION OF MOUSE FIBROBLASTS WITH THE ONCOGENES H-RAS OR TRK IS ASSOCIATED WITH PRONOUNCED CHANGES IN DRUG SENSITIVITY AND METABOLISM, International journal of cancer, 54(3), 1993, pp. 450-455
Authors:
VANDERWILT CL
VISSER GWM
BRAAKHUIS BJM
WEDZINGA R
NOORDHUIS P
SMID K
PETERS GJ
Citation: Cl. Vanderwilt et al., IN-VITRO ANTITUMOR-ACTIVITY OF CIS-5-FLUORO-5,6-DIHYDRO-6-ALKOXY-URACIL AND TRANS-5-FLUORO-5,6-DIHYDRO-6-ALKOXY-URACIL - EFFECTS ON THYMIDYLATE SYNTHESIS, British Journal of Cancer, 68(4), 1993, pp. 702-707
Authors:
BRAAKHUIS BJM
JANSEN G
NOORDHUIS P
KEGEL A
PETERS GJ
Citation: Bjm. Braakhuis et al., IMPORTANCE OF PHARMACODYNAMICS IN THE IN-VITRO ANTIPROLIFERATIVE ACTIVITY OF THE ANTIFOLATES METHOTREXATE AND 10-ETHYL-10-DEAZAAMINOPTERIN AGAINST HUMAN HEAD AND NECK SQUAMOUS-CELL CARCINOMA, Biochemical pharmacology, 46(12), 1993, pp. 2155-2161
Authors:
EDZES HT
PETERS GJ
NOORDHUIS P
VERMORKEN JB
Citation: Ht. Edzes et al., DETERMINATION OF THE ANTIMETABOLITE GEMCITABINE (2',2'-DIFLUORO-2'-DEOXYCYTIDINE) AND OF 2',2'-DIFLUORO-2'-DEOXYURIDINE BY F-19 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY, Analytical biochemistry, 214(1), 1993, pp. 25-30